It has come to our attention that there are scam letters being mailed to TCC patients stating that the patient will “no longer be seen in our office”. The letters are typed on blank paper without a date or additional information or explanation.
PLEASE contact our office immediately if you receive any correspondence that appears suspicious. The physicians and staff of Toledo Cardiology Consultants value all of our patient relationships and we will continue to provide you with outstanding cardiac care.
•We are glad to welcome Heminder Singh, MD to TCC Family
•Dr. Singh specializes in coronary and peripheral interventions and is board certified in Cardiovascular diseases, Echocardiography and Nuclear Cardiology
•He will be accepting patients from July 2020
COVID-19 Get Your Questions Answered.
Based on what we know now, those at high-risk for severe illness from COVID-19 are:
People who live in a nursing home or long-term care facility
People of all ages with underlying medical conditions, particularly if not well controlled, including:
People with chronic lung disease or moderate to severe asthma
People who have serious heart conditions
People who are immunocompromised
Many conditions can cause a person to be immunocompromised, including cancer treatment, smoking, bone marrow or organ transplantation, immune deficiencies, poorly controlled HIV or AIDS, and prolonged use of corticosteroids and other immune weakening medications
People with severe obesity (body mass index [BMI] of 40 or higher)
People with diabetes
People with chronic kidney disease undergoing dialysis
People with liver disease
As people are advised to stay home and as the list of gathering places being closed to limit the spread of the coronavirus grows, people might find themselves shut out of their gym, or choose not to go.
But that doesn't mean they should give up on the idea of fitness entirely, trainers say.
And people who do find places to work out in the weeks ahead will want to be aware that gyms can be germy – and they should take steps to protect themselves.
Read all CDC recommendation about exercise during the pandemic time
TCC Virtual Visits
Click the Telehealth button to schedule your appointment
You just need an email and phone number, then receive confirmation and code
Or call our offices at 419-517-8121 or 419-251-3700
Heart Patients Warned of Risks from Coronavirus
The coronavirus disease 2019 (COVID-19) is starting to hit home for many people in America. The World Health Organization classified it as a pandemic this week, as the outbreak now extends across the globe. Communities are working together to limit its spread. Schools are closing, conferences and public events are being canceled—even professional and college sports have either canceled tournaments or suspended their seasons.
While everyone is on alert, people with heart disease seem to be at higher risk of developing serious illness from COVID-19. The American College of Cardiology has issued a clinical bulletin to offer guidance about the coronavirus and treating patients with heart conditions (“COVID-19 Clinical Guidance For the Cardiovascular Care Team”). Although what we know is changing rapidly, here are important takeaways for patients and their families.
Hydroxychloroquine linked to increased risk of cardiac arrhythmias
In a new report, a team of pharmacists and clinicians found evidence suggesting that patients who received hydroxychloroquine for COVID-19 were at increased risk of electrical changes to the heart and cardiac arrhythmias. The combination of hydroxychloroquine with azithromycin was linked to even greater changes compared to hydroxychloroquine alone.
"If considering the use of hydroxychloroquine, particularly combined with azithromycin, clinicians should carefully weigh the risks and benefits, and closely monitor QTc -- particularly considering patients' co-morbidities and concomitant medication use," said senior author Howard S. Gold, MD, an infectious disease specialist at BIDMC and an assistant professor of medicine at Harvard Medical School. "Based on our current knowledge, hydroxychloroquine for the treatment of COVID-19 should probably be limited to clinical trials."
2/3 of Patient treated with statin failed to achieve their goal.
The majority of patients with acute coronary syndrome (ACS) treated with statins were found to have low-density lipoproteins-cholesterol (LDL-C) levels above those recommended by current guidelines.
The study suggest that patient post acute cardiac events still having difficulty achieving target LDL (Bad cholesterol) appropriate numbers. That open the question to what else could be done to achieve their goal.